Journal of LipidsPub Date : 2020-07-28eCollection Date: 2020-01-01DOI: 10.1155/2020/8853940
Dilini N Perera, Geeth G Hewavitharana, S B Navaratne
{"title":"Determination of Physicochemical and Functional Properties of Coconut Oil by Incorporating Bioactive Compounds in Selected Spices.","authors":"Dilini N Perera, Geeth G Hewavitharana, S B Navaratne","doi":"10.1155/2020/8853940","DOIUrl":"10.1155/2020/8853940","url":null,"abstract":"<p><p>Lipid oxidation has been identified as a major deterioration process of vegetable oils, which leads to the production of primary and secondary oxidative compounds that are harmful to human health. Oleoresins of ginger, garlic, nutmeg, pepper, cloves, and cinnamon were extracted and incorporated into coconut oil, and change occurrence on physicochemical properties, thermal stability, shelf life, and antioxidant activity was monitored against the same properties of pure coconut oil. Lipid oxidation was assessed in terms of the free fatty acid level and peroxide value. For the comparison purpose, another oil sample was prepared by incorporating vitamin E too. Results revealed that both peroxide value and FFA of pure and flavored coconut oil samples after a one-week storage period were 3.989 ± 0.006 and 3.626 ± 0.002 mEq/kg and 0.646 ± 0.001 and 0.604 ± 0.002 (%), respectively. Saponification value, iodine value, smoke point, and the flashpoint of flavored oil were decreased while increasing the viscosity during storage. The highest phenolic content and DPPH free radical scavenging activity were found in flavored coconut oil. Since spices containing antioxidants, the thermal stability of flavored oil was better than that of pure coconut oil. Both oleoresins and vitamin E-incorporated samples showed the same pattern of increment of FFA and peroxide value during storage; however, those increments were slower than those of pure coconut oil.</p>","PeriodicalId":16274,"journal":{"name":"Journal of Lipids","volume":"2020 ","pages":"8853940"},"PeriodicalIF":5.3,"publicationDate":"2020-07-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7407039/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38256300","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Journal of LipidsPub Date : 2020-02-01eCollection Date: 2020-01-01DOI: 10.1155/2020/3491764
Motasim M Jawi, Jiri Frohlich, Sammy Y Chan
{"title":"Lipoprotein(a) the Insurgent: A New Insight into the Structure, Function, Metabolism, Pathogenicity, and Medications Affecting Lipoprotein(a) Molecule.","authors":"Motasim M Jawi, Jiri Frohlich, Sammy Y Chan","doi":"10.1155/2020/3491764","DOIUrl":"10.1155/2020/3491764","url":null,"abstract":"<p><p>Lipoprotein(a) [Lp(a)], aka \"Lp little a\", was discovered in the 1960s in the lab of the Norwegian physician Kåre Berg. Since then, we have greatly improved our knowledge of lipids and cardiovascular disease (CVD). Lp(a) is an enigmatic class of lipoprotein that is exclusively formed in the liver and comprises two main components, a single copy of apolipoprotein (apo) B-100 (apo-B100) tethered to a single copy of a protein denoted as apolipoprotein(a) apo(a). Plasma levels of Lp(a) increase soon after birth to a steady concentration within a few months of life. In adults, Lp(a) levels range widely from <2 to 2500 mg/L. Evidence that elevated Lp(a) levels >300 mg/L contribute to CVD is significant. The improvement of isoform-independent assays, together with the insight from epidemiologic studies, meta-analyses, genome-wide association studies, and Mendelian randomization studies, has established Lp(a) as the single most common independent genetically inherited causal risk factor for CVD. This breakthrough elevated Lp(a) from a biomarker of atherosclerotic risk to a target of therapy. With the emergence of promising second-generation antisense therapy, we hope that we can answer the question of whether Lp(a) is ready for prime-time clinic use. In this review, we present an update on the metabolism, pathophysiology, and current/future medical interventions for high levels of Lp(a).</p>","PeriodicalId":16274,"journal":{"name":"Journal of Lipids","volume":"2020 ","pages":"3491764"},"PeriodicalIF":5.9,"publicationDate":"2020-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7016456/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37677201","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"A Transcriptional Regulatory System of theS. cerevisiae OLE1Gene Responds to Fatty Acid Species and Intracellular Amount, and not Simply Membrane Status","authors":"M. Willey, M. Ochs, Clara Busse, V. McDonough","doi":"10.1155/2020/3903257","DOIUrl":"https://doi.org/10.1155/2020/3903257","url":null,"abstract":"We examined the effects of unsaturated fatty acid (UFA) species and their concentration on the expression ofOLE1,which encodes the stearoyl CoA desaturase, inSaccharomyces cerevisiae. We controlled the amount of UFA taken up by the cell by varying the concentration of tergitol in the medium. When cultured with 1 mM fatty acid in 0.1% tergitol, cells took up much more fatty acid than when cultured with the same concentration of fatty acid at 1% tergitol, although the amount incorporated was dependent on UFA species. For each fatty acid tested, we found that the higher uptake (0.1% tergitol condition) had a stronger impact onOLE1regulation. A principal product of the desaturase 16:1∆9, and the nonnative UFA 18:2∆9,12, most strongly repressed the reporter constructOLE1-lacZtranscription, while the other major product of the desaturase, 18:1∆9, and the nonnative UFA 17:1∆10 caused a more diminished response. Based on these results, our initial hypothesis was thatOLE1was regulated in response to membrane fluidity; however, subsequent work does not support that idea; we have found that conditions that affect membrane fluidity such as growth temperature and growth with saturated ortransfatty acid supplementation, do not regulateOLE1in the direction predicted by fluidity changes. We conclude that at least one signal that regulatesOLE1transcriptional expression is most likely based on the fatty acids themselves.","PeriodicalId":16274,"journal":{"name":"Journal of Lipids","volume":"1 1","pages":""},"PeriodicalIF":5.3,"publicationDate":"2020-01-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"88120348","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Journal of LipidsPub Date : 2020-01-23eCollection Date: 2020-01-01DOI: 10.1155/2020/8469830
Fahadah Naeef Alsoodeeri, Hissah Mohammed Alqabbani, Norah Mubarak Aldossari
{"title":"Effects of Cinnamon (<i>Cinnamomum cassia</i>) Consumption on Serum Lipid Profiles in Albino Rats.","authors":"Fahadah Naeef Alsoodeeri, Hissah Mohammed Alqabbani, Norah Mubarak Aldossari","doi":"10.1155/2020/8469830","DOIUrl":"https://doi.org/10.1155/2020/8469830","url":null,"abstract":"<p><p>Dyslipidemia is an important cause of cardiovascular diseases (CVDs), which are the most prevalent causes of morbidity and mortality. The purpose of this study was to assess the effects of cinnamon on body weight gain, food intake, and serum lipid profiles of albino rats. This study was conducted on 30 healthy male albino rats weighing approximately 130 ± 5 g. The study was divided into the following two experiments: experiment (1), wherein rats were fed a laboratory diet; and experiment (2), wherein rats were fed a high-fat diet. In experiment 1, a total of 15 rats were divided into three groups. Group A (<i>n</i> = 5, untreated control) was fed laboratory diet, Group B (<i>n</i> = 5) was fed laboratory diet and cinnamon powder (2 g/kg body weight), and Group C (<i>n</i> = 5) was fed laboratory diet and cinnamon powder (4 g/kg body weight) for 30 days. In experiment (2), a total of 15 rats were similarly divided into three groups. Group D (<i>n</i> = 5, treated control) was fed laboratory diet plus high-fat diet, Group E (<i>n</i> = 5) was fed cinnamon powder (2 g/kg body weight) mixed with laboratory diet plus high-fat diet, and Group F (<i>n</i> = 5) was fed cinnamon powder (4 g/kg body weight) mixed with laboratory diet plus high-fat diet daily for 30 days. An administration of 4 g/kg body weight of cinnamon extract powder decreased the final weight by 4.4%, body weight gains by 31.41%, food intake by 1.7%, and food efficiency ratio by 22.38% in hypercholesterolemic adult male rats as well as serum total cholesterol by 31.22%, triglyceride by 24.05%, and LDL-C by 43.49%, with an increase in the levels of HDL-C by 30.16%, furthermore, a significant decrease in serum total cholesterol, triglycerides, and LDL-C levels and increasing serum HDL-C on day 30 were observed (<i>P</i> < 0.001). This finding provides scientific evidence to substantiate the traditional use of cinnamon to treat hyperlipidemia.</p>","PeriodicalId":16274,"journal":{"name":"Journal of Lipids","volume":"2020 ","pages":"8469830"},"PeriodicalIF":5.3,"publicationDate":"2020-01-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2020/8469830","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37937976","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Journal of LipidsPub Date : 2020-01-20eCollection Date: 2020-01-01DOI: 10.1155/2020/5704752
Kamal A Amin, Abdelgadir M Homeida, Reda H ElMazoudy, Khalid S Hashim, Mahdi Garelnabi
{"title":"Corrigendum to \"Dietary Lipids in Health and Disease\".","authors":"Kamal A Amin, Abdelgadir M Homeida, Reda H ElMazoudy, Khalid S Hashim, Mahdi Garelnabi","doi":"10.1155/2020/5704752","DOIUrl":"https://doi.org/10.1155/2020/5704752","url":null,"abstract":"<p><p>[This corrects the article DOI: 10.1155/2019/5729498.].</p>","PeriodicalId":16274,"journal":{"name":"Journal of Lipids","volume":"2020 ","pages":"5704752"},"PeriodicalIF":5.3,"publicationDate":"2020-01-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2020/5704752","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37923434","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Iyad Ali, Aya Kharma, Malaka Samara, Samar Odeh, N. Jaradat, A. Zaid, Mahdi Al Sayed Ahmad
{"title":"Prevalence of Dyslipidemia in Undiagnosed Palestinian Men: A Cross-Sectional Study","authors":"Iyad Ali, Aya Kharma, Malaka Samara, Samar Odeh, N. Jaradat, A. Zaid, Mahdi Al Sayed Ahmad","doi":"10.1155/2019/3473042","DOIUrl":"https://doi.org/10.1155/2019/3473042","url":null,"abstract":"Introduction Dyslipidemia is the most important modifiable risk factor that leads to cardiovascular diseases. The screening for dyslipidemia in Palestine is not established in primary health care centers for healthy people. Our study aims to determine the prevalence of dyslipidemia among healthy undiagnosed adult men in Palestine in order to assess the need for screening and preventive programs for dyslipidemia. Materials and Methods A cross-sectional observational study was carried out in 10 secondary schools at Nablus municipality (Palestine) from August 2017 to February 2018. The study included 140 teachers based on sample calculations. The age of participants ranged between 24 and 60 years. A questionnaire was used to collect demographic data about the lifestyle, past medical, and family histories. Serum lipid profile, and fasting blood glucose levels for each participant were measured. Lipoprotein levels were categorized based on the adult treatment panel III criteria. Results The overall prevalence of dyslipidemia among Palestinian men was 66.4%. The most prevalent type of dyslipidemia was hypo HDL (X < 40 mg/dl, 59.3%), followed by hypertriglyceridemia (X ≥ 200 mg/dl, 20%). The prevalence of hyper LDL (X ≥ 160 mg/dl), hypercholesterolemia (X ≥ 240 mg/dl) was 8.5%, and 3.6%, respectively. About 15% of participants had glucose intolerance, and 4.3% had hyperglycemia (undiagnosed). Those with glucose intolerance, 13 (9.2%) have hypo HDL, while 9 (6.42%) have hypertriglyceridemia. On the other hand, out of hyperglycemic patients: 5 (3.5%) had hypo HDL, and 1 (0.7%) had hypertriglyceridemia. Conclusion Around two-thirds of undiagnosed participants had at least one lipid abnormality. None of them were aware of having dyslipidemia. The prevalence of undiagnosed dyslipidemia was higher than the prevalence of undiagnosed glucose intolerance, and diabetes. This suggests that dyslipidemia plays a major role in developing diabetes. Hence, profound efforts should be done to manage and treat those with dyslipidemia, in order to prevent progression to type II diabetes mellitus.","PeriodicalId":16274,"journal":{"name":"Journal of Lipids","volume":"21 1","pages":""},"PeriodicalIF":5.3,"publicationDate":"2019-10-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"78263299","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
K. Amin, A. M. Homeida, Reda H. El Mazoudy, Khalid S. Hashim, M. Garelnabi
{"title":"Dietary Lipids in Health and Disease","authors":"K. Amin, A. M. Homeida, Reda H. El Mazoudy, Khalid S. Hashim, M. Garelnabi","doi":"10.1155/2019/5729498","DOIUrl":"https://doi.org/10.1155/2019/5729498","url":null,"abstract":"","PeriodicalId":16274,"journal":{"name":"Journal of Lipids","volume":"272 1","pages":""},"PeriodicalIF":5.3,"publicationDate":"2019-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"73650587","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
L. Kaddam, imad Mohamed Fadl Elmula, O. A. Eisawi, Haydar Awad Abdelrazig, A. Saeed
{"title":"Acacia Senegal (Gum Arabic) Supplementation Modulate Lipid Profile and Ameliorated Dyslipidemia among Sickle Cell Anemia Patients","authors":"L. Kaddam, imad Mohamed Fadl Elmula, O. A. Eisawi, Haydar Awad Abdelrazig, A. Saeed","doi":"10.1155/2019/3129461","DOIUrl":"https://doi.org/10.1155/2019/3129461","url":null,"abstract":"Background Sickle cell disease (SCD) is an inherited haemolytic anemia with a variable course and severity. Knowledge of prognostic biomarkers may help in the establishment of therapeutic intervention, management, and follow-up of patients. There have been scattered reports of low high-density lipoprotein cholesterol (HDL-C) and increased triglyceride (TG) in SCD patients. In addition, TG levels have been suggested to be elevated in patients with increased endothelial activation. An increased TG level has been associated with haemolysis, vascular dysfunction, and increased prevalence of pulmonary hypertension. Gum Arabic (GA) is an edible, dried, gummy exudate from the acacia Senegal tree. Several studies on GA ingestion have shown reduced plasma cholesterol and low-density lipoprotein (LDL) concentrations in both animals and humans. We investigated GA's therapeutic potential to modulate serum lipids in patients with sickle cell anemia. Methods This study recruited and documented secondary outcomes in 47 patients (aged 5–42 years) carrying hemoglobin SS. The patients received 30 g/day of GA for 12 weeks. Total cholesterol, TG, LDL, and HDL were measured before and after GA intake. Cobas C311 (Roche, Germany) automated chemistry analyser was used for direct determination of the values of the lipid profile. Results GA significantly decreased total cholesterol (TC), TG, and LDL (p = 0.006, 0.04, and 0.02, resp.). GA showed no effect on HDL level. Baseline serum TG and LDL correlated significantly with the hydrogen peroxide (H2O2) level, which is known as an oxidative stress marker (p = 0.003 and 0.04, resp.). None of the lipid profile elements correlated with age. Conclusion Our results revealed that dyslipidemia in sickle cell patients is associated with oxidative stress but not associated with age. The findings showed that GA significantly decreased TC, LDL, and TG levels, revealing a novel effect of GA, which is considered a natural dietary fibre that can modulate lipid profile in patients with sickle cell anemia. Trial Registration This retrospective trial is registered with ClinicalTrials.gov Identifier: NCT02467257 on 3 June, 2015.","PeriodicalId":16274,"journal":{"name":"Journal of Lipids","volume":"23 1","pages":""},"PeriodicalIF":5.3,"publicationDate":"2019-06-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"88851517","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Scavenger Receptor Class B Member 1 Independent Uptake of Transthyretin by Cultured Hepatocytes Is Regulated by High Density Lipoprotein","authors":"K. Landers, M. d’Emden, K. Richard","doi":"10.1155/2019/7317639","DOIUrl":"https://doi.org/10.1155/2019/7317639","url":null,"abstract":"Thyroid hormone (thyroxine, T4) is essential for the normal function of all cell types and is carried in serum bound to several proteins including transthyretin. Recently, evidence has emerged of alternate pathways for hormone entry into cells that are dependent on hormone binding proteins. Transthyretin and transthyretin bound T4 are endocytosed by placental trophoblasts through the high-density lipoprotein receptor, Scavenger Receptor Class B Type 1 (SR-B1). High density lipoprotein (HDL) affects the expression and function of SR-B1 in trophoblast cells. SR-B1 is also expressed in hepatocytes and we sought to determine if hepatocyte SR-B1 was involved in transthyretin or transthyretin-T4 uptake and whether uptake was affected by HDL. Transthyretin and transthyretin-T4 uptake by hepatocytes is not dependent on SR-B1. HDL treatment reduced SR-B1 expression. However, pretreatment of hepatocytes with HDL increased uptake of transthyretin-T4. Knockdown of SR-B1 expression using siRNA also increased transthyretin-T4 uptake. Coaddition of HDL to transthyretin uptake experiments blocked both transthyretin and transthyretin-T4 uptake. Hepatocyte uptake of transthyretin-T4 uptake is influenced by, but is not dependent on, SR-B1 expression. HDL also decreases transthyretin-T4 uptake and therefore diet or drugs may interfere with this process. This suggests that multiple lipoprotein receptors may be involved in the regulation of uptake of transthyretin-T4 in a cell-type specific manner. Further study is required to understand this important process.","PeriodicalId":16274,"journal":{"name":"Journal of Lipids","volume":"1 1","pages":""},"PeriodicalIF":5.3,"publicationDate":"2019-06-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"75010076","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Journal of LipidsPub Date : 2019-04-30eCollection Date: 2019-01-01DOI: 10.1155/2019/2517013
Rea Ariyanti, Besral Besral
{"title":"Dyslipidemia Associated with Hypertension Increases the Risks for Coronary Heart Disease: A Case-Control Study in Harapan Kita Hospital, National Cardiovascular Center, Jakarta.","authors":"Rea Ariyanti, Besral Besral","doi":"10.1155/2019/2517013","DOIUrl":"https://doi.org/10.1155/2019/2517013","url":null,"abstract":"<p><p><i>Background.</i> Coronary Heart Disease (CHD) is the main highlight of the major cardiovascular diseases. In Indonesia, CHD is the leading cause of death from all deaths, with rates reaching 26.4%, which is four times greater than cancer mortality rates. <i>Objective.</i> This study aims to determine whether dyslipidemia associated with hypertension increases the risks for the incidence of CHD in Harapan Kita Hospital, National Cardiovascular Center, Jakarta, or does not. <i>Methods.</i> The study design was case control. The sample was 163 respondents, 82 respondents in the case group and 81 respondents in the control group. The data were analyzed by using logistic regression. <i>Results.</i> In the CHD group, the percentage of respondents with dyslipidemia was 50%, while in the control group, the percentage of respondents with dyslipidemia was 17.3%. The relationship of dyslipidemia with the incidence of CHD differed according to hypertension status. After being controlled for age, in hypertensive respondents, those with dyslipidemia was 18.1 times more likely to develop CHD compared with those nondyslipidemic, whereas in nonhypertensive respondents, those with dyslipidemia was 2.5 times more likely to develop CHD compared with those nondyslipidemic. <i>Recommendation.</i> It is recommended that the community have medical checkup regularly and change lifestyles by taking healthy diet to control lipid profile and blood pressure.</p>","PeriodicalId":16274,"journal":{"name":"Journal of Lipids","volume":"2019 ","pages":"2517013"},"PeriodicalIF":5.3,"publicationDate":"2019-04-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2019/2517013","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37055488","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}